https://outruntx.com/outrun-therapeutics-launches-with-a-10m-seed-financing-from-m-ventures-and-mp-healthcare-venture-management-to-develop-a-protein-stabilisation-pipeline/2024-04-18T09:20:31+01:00https://outruntx.com/outrun-therapeutics-expands-leadership-team-with-appointment-of-matthew-fyfe-as-chief-scientific-officer/2026-03-17T15:11:33+00:00https://outruntx.com/site-resolved-assessment-of-targeted-protein-degradation-2/2025-08-05T16:28:28+01:00https://outruntx.com/site-resolved-assessment-of-targeted-protein-degradation/2025-08-14T14:36:55+01:00https://outruntx.com/outrun-therapeutics-unveils-lead-programme-targeting-hpv-positive-head-and-neck-cancer-and-appoints-renowned-e3-ligase-experts-to-scientific-advisory-board-sab/2026-03-17T08:30:03+00:00https://outruntx.com/znfx1-uses-two-component-ubiquitin-circuitry-to-quarantine-viral-rna/2026-04-02T17:26:46+01:00